Trial record 1 of 1 for:    strive anti-jcv
Previous Study | Return to List | Next Study

Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients (STRIVE)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2012 by Biogen Idec.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Biogen Idec Identifier:
First received: December 1, 2011
Last updated: September 12, 2013
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given